SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Multiple acquisition offers for ZIM Integrated Shipping Services, including bids from major international shipping firms, are currently sparking intense community discussion after the board rejected the CEO's internal proposal as significantly undervalued. Investors are keenly watching for a potential bidding war, emphasizing the company's substantial cash holdings and intrinsic worth, while also considering the Israeli government's critical role in approving any sale due to national security and worker concerns.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token (VVV) is trending due to recent token burns, a permanent reduction in its annual emission rate, and surging platform activity for its private, uncensored AI services. The community highlights its significant undervaluation compared to AI peers, anticipating further growth given its strong tokenomics and increasing utility in the AI sector.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

UniSwap is gaining significant attention following a highly anticipated governance proposal to activate a protocol fee switch and implement a substantial token burn, which the community overwhelmingly supports. This potential change in tokenomics, alongside reported institutional interest, is driving widespread bullish discussion about UNI's future value.

Aztec is the leading privacy-first Layer 2 on Ethereum, empowering developers to build applications that protect user privacy. Backed by a $100M Series B led by a16z, Aztec is led by a team of world-class cryptographers who invented the standard for trustless client-side proving—making privacy-preserving apps possible.  In a landscape where speed and novelty rarely translate into durable moats, Aztec’s sustained traction, deep institutional adoption, and growing ecosystem around privacy-preserving cryptography validate that its work has broken through the “flock,” proving privacy isn’t a feature race but a foundational technology trusted to underpin real, long-term financial infrastructure.   1. Pioneers of Privacy in Web3 Aztec's team developed PLONK in 2019, a SNARK-based proving system that is computationally inexpensive and only requires one universal trusted setup. PLONK was a big breakthrough, not just for Aztec, but for the wider blockchain community. Today, PLONK has been implemented and extended by teams like zkSync, Polygon, Mina, and more. There is even an entire category of proving systems called PLONKish that all derive from the original 2019 paper. The foundational cryptography behind modern privacy infrastructure was built by the Aztec team.  2. Noir: The Universal ZK Programming Language The Aztec Labs team developed Noir, a Rust-like programming language for writing zero-knowledge circuits that make privacy technology accessible to mainstream developers. With 500+ GitHub projects and recognition as Electric Capital’s top 5 fastest-growing developer ecosystems, Noir is becoming the standard for zk development and is used today by projects across Solana, Stellar, Starkware, and World.   3. Drawing Institutional Attention Across Tradfi, Stablecoins, and Real-World Assets  JP Morgan was an early institutional tester of Aztec’s technology, with its Quorum blockchain team actively evaluating and experimenting with Aztec as part of its effort to industrialize privacy-preserving cryptography for regulated financial use cases back in 2019.  The Taurus confidential token standard was built on Aztec’s technology and adopted by a leading institutional infrastructure provider. This proves that Aztec is not just a research project, but a credible, production-ready platform and a foundational player in the privacy-preserving financial infrastructure stack.

Aztec

AZTEC is trending following its Token Generation Event (TGE) and rare multi-exchange listings on major platforms like Coinbase, Kraken, and Bybit, with Binance also launching perpetual futures. The community is actively discussing its utility as a privacy-focused Ethereum Layer 2 solution utilizing Zero Knowledge Proofs (ZKP), underscored by high praise from the UniSwap founder and significant institutional interest.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending due to ecosystem growth, including new perpetual listings and institutional integrations with Franklin Templeton and BlackRock on BNB Chain, alongside its addition to Grayscale's Crypto 5 ETF. However, community discussion remains deeply divided amid persistent accusations of market manipulation against the exchange.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is trending amidst news of a substantial IRS tax refund that significantly boosts its liquidity and strategic advancements in 300mm silicon carbide wafers and AI-powered manufacturing for high-growth sectors. The community is sharply divided between those foreseeing a post-restructuring growth story, especially in AI infrastructure, and those wary of its past financial challenges and continued path to profitability.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Satellos Bioscience is trending after its NASDAQ listing, a recent financing round following a reverse split, and an Oppenheimer price target upgrade for its Duchenne muscular dystrophy (DMD) program. Community sentiment is split between optimism for its novel drug candidate, SAT-3247, and concerns about share dilution and historical stock performance.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending as it weighs an updated $30/share offer from Paramount Skydance, including financial protections, against Netflix's $27.75/share bid, intensely debated by the community amidst regulatory scrutiny and WBD's significant debt.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Tandem Diabetes Care is trending as community members discuss its potential undervaluation given its market cap relative to revenue, with some suggesting it's a prime buying opportunity. Bullish sentiment is fueled by anticipation of future growth, while others express concerns about competition and past performance. Discussions also include speculation about a potential buyout and debate over the company's leadership.

Sperax is redefining financial autonomy through programmable agents that manage capital, optimize yield, and protect against risk, all transparently on-chain. Founded in 2019, Sperax is backed by leading investors including Jump Trading, Polychain Capital, Amber Group. Sperax offers a new standard in automated, user-driven finance.  The SperaxOS ecosystem is powered by USDs and SPA on Arbitrum, BNB Chain, and other EVM networks. Anchored by two native assets: USDs, a gas-free, auto-yield stablecoin backed by on-chain collateral, and SPA, the governance and value-capture token. Sperax builds open-source tools that turn idle capital into self-optimizing portfolios.  SperaxOS is a cross-chain financial operating system where AI-driven smart agents automate everything from yield farming to payroll, and Demeter, a no-code platform for launching liquidity farms. USDs automatically rebases yield to holders, while SPA lets users register agents, earn protocol fees, and vote on upgrades. Battle-tested through multiple market cycles: Sperax offers individuals, DAOs, and fintechs a borderless toolkit for passive income, risk-managed investing, and fully automated treasury operations, all governed on-chain by its community.

Sperax

Sperax ($SPA) is trending with unusual trading volume as the community actively accumulates tokens, anticipating the imminent launch of SperaxOSan AI-powered yield system based on its compliant stablecoin, $USDswhich many believe positions it favorably amidst evolving stablecoin regulations and potential Tier 1 exchange listings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LSV Asset Management Sells 41,884 Shares of Jazz Pharmaceuticals PLC $JAZZ

LSV Asset Management lessened its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 1.6% during the third quarter, according to the company in its most recent 13F filing with the...

Is the Options Market Predicting a Spike in Jazz Pharmaceuticals Stock?

Investors need to pay close attention to Jazz Pharmaceuticals stock based on the movements in the options market lately.

Essex Investment Management Co. LLC Invests $2.70 Million in Jazz Pharmaceuticals PLC $JAZZ

Essex Investment Management Co. LLC purchased a new stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with...

Moderna to Report Q4 Earnings: Is a Beat in Store for the Stock?

MRNA is set to report Q4 results on Feb. 13, with expectations for an earnings beat as COVID vaccine sales and pipeline updates stay in focus.

Renaissance Group LLC Sells 7,254 Shares of Jazz Pharmaceuticals PLC $JAZZ

Renaissance Group LLC lessened its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 12.9% during the third quarter, according to the company in its most recent Form 13F...

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eighteen analysts that are presently covering the firm, MarketBeat...

Allianz Asset Management GmbH Purchases 30,537 Shares of Jazz Pharmaceuticals PLC $JAZZ

Allianz Asset Management GmbH lifted its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 9.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The...

New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings

Biogen heads into Q4 earnings with MS drug pressure, while Leqembi and Skyclarys' growth could help offset declines ahead of its Feb. 6 report.

What is Zacks Research's Estimate for JAZZ Q1 Earnings?

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) - Zacks Research lifted their Q1 2027 earnings estimates for Jazz Pharmaceuticals in a research note issued to investors on Monday, February 2nd...

Strs Ohio Sells 14,393 Shares of Jazz Pharmaceuticals PLC $JAZZ

Strs Ohio reduced its stake in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 91.2% during the third quarter, according to its most recent Form 13F filing with the Securities and...

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals plc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$6.52	--	--	N/A
Q3 '25	$5.80	$8.13	40.14%	BEAT
Q2 '25	-$7.61	-$8.25	-8.47%	MISSED
Q1 '25	$4.66	$1.68	-63.93%	MISSED
Q4 '24	$5.81	$6.60	13.58%	BEAT

JAZZ
Jazz Pharmaceuticals plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest JAZZ News

JAZZJazz Pharmaceuticals plc